RxDoctor Payments Data

Elizabeth Pritchard

Physician Assistant · Augusta, MENPI 1073943635

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 366 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,345in general payments, 2019–2025

Across 366 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • Amgen$532
  • Boehringer Ingelheim$522
  • Exact Sciences$470
  • GSK$456
  • Novo Nordisk$366
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$6,19898%
  • Education$1472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,345 in reported general payments places this provider in the 95th percentile of 774 physician assistant providers in Maine.

See all physician assistant providers in Maine

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin54$88,375
OzempicSemaglutide70$78,465
EliquisApixaban38$64,750
TrulicityDulaglutide15$35,286
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$29,504
JanuviaSitagliptin Phosphate16$26,458
MyrbetriqMirabegron19$25,344
ProliaDenosumab11$19,425
WegovySemaglutide12$16,190
MounjaroTirzepatide13$13,673
XareltoRivaroxaban11$13,665
Breo ElliptaFluticasone/Vilanterol14$9,025
Tresiba Flextouch U-100Insulin Degludec22$7,474
Pregabalin20$3,693
Atorvastatin Calcium230$2,457

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$366$94,65582 claims
Boehringer IngelheimJardiance$522$88,37554 claims
PfizerEliquis$1,141$64,75038 claims
Lilly USA, LLCTrulicity, Mounjaro$92$48,95828 claims
GSKTrelegy Ellipta, Breo Ellipta$456$38,52929 claims
MerckJanuvia$333$26,45816 claims
Astellas Pharma US IncMyrbetriq$295$25,34419 claims
AmgenProlia$532$19,42511 claims
Johnson & JohnsonXarelto$34$13,66511 claims
AbbVieSynthroid$210$1,17016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 774 physician assistant providers in Maine.

Other physician assistant in Augusta

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →